Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
<p>Background</p> Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel...
Prif Awduron: | Salman, R, Minks, DP, Mitra, D, Rodrigues, MA, Bhatnagar, P, Du Plessis, JC, Joshi, Y, Dennis, MS, Murray, GD, Newby, DE, Sandercock, PAG, Sprigg, N, Stephen, J, Sudlow, CLM, Werring, DJ, Whiteley, WN, Wardlaw, JM, White, PM, Restart Collaboration, Armitage, J |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
Elsevier
2019
|
Eitemau Tebyg
-
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
gan: Salman, R, et al.
Cyhoeddwyd: (2018) -
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
gan: Baigent, C, et al.
Cyhoeddwyd: (2019) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
gan: Rustam Al-Shahi Salman, et al.
Cyhoeddwyd: (2018-03-01) -
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial
gan: Rustam Al-Shahi Salman, et al.
Cyhoeddwyd: (2019-03-01) -
Cerebral Amyloid Angiopathy and Intracerebral Haemorrhage
gan: David Werring, et al.
Cyhoeddwyd: (2016-09-01)